Therapeutic Activity of DCC ‐2036, a Novel Tyrosine Kinase Inhibitor, against Triple‐Negative Breast Cancer Patient‐Derived Xenografts by Targeting AXL/MET

International Journal of Cancer,Volume 0, Issue ja, -Not available-.

Source: International Journal of Cancer - October 5, 2018 Category: Cancer & Oncology Authors: Yingying Shen, Wei Zhang, Jianghua Liu, Jun He, Renxian Cao, Xiguang Chen, Xiuda Peng, Haifan Xu, Qiang Zhao, Jing Zhong, Wenjun Ding, Xiaoyong Lei, Yuyang Jiang, Xuyu Zu Source Type: research